| Jennifer Noel Lennington, MD | |
|
350 S Landmark Ave, Bloomington, IN 47403-5001 | |
| (812) 335-2435 | |
| (812) 330-2306 |
| Full Name | Jennifer Noel Lennington |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 350 S Landmark Ave, Bloomington, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194973255 | NPI | - | NPPES |
| 201326280 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01075522A (Indiana) | Primary |
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has expanded its compassionate use program for PV-10, making the agent, which is being developed as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients in the United States. The program is already in progress in Australia, where it was initiated in June 2009.
Good health helps children with stressful transitions from elementary school to middle school, finds a new study in the Journal of Adolescent Health. Students with chronic conditions such as asthma, obesity, learning disabilities, attention-deficit hyperactivity disorder, and those with health-related needs, were noted to have lower academic performances.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Noel Lennington, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Jennifer Noel Lennington, MD 350 S Landmark Ave, Bloomington, IN 47403-5001 Ph: (812) 335-2435 |
News Archive
Certain complications during and immediately after birth are associated with the development of the eating disorders anorexia nervosa and bulimia nervosa, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has expanded its compassionate use program for PV-10, making the agent, which is being developed as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients in the United States. The program is already in progress in Australia, where it was initiated in June 2009.
Good health helps children with stressful transitions from elementary school to middle school, finds a new study in the Journal of Adolescent Health. Students with chronic conditions such as asthma, obesity, learning disabilities, attention-deficit hyperactivity disorder, and those with health-related needs, were noted to have lower academic performances.
› Verified 4 days ago
Audra Janice Kunzman-mazdzer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 350 S Landmark Ave, Bloomington, IN 47403 Phone: 812-335-2434 Fax: 812-335-7604 | |
Dr. John Stephen Schechter, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 719 W 1st St, Bloomington, IN 47403 Phone: 812-339-6151 Fax: 812-339-8884 | |
Dr. Minxin Fu, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 651 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-333-2304 Fax: 812-330-2306 | |
Dr. Sandra C. Castro, MD, FAAP, CHCQM Pediatrics Medicare: Medicare Enrolled Practice Location: 350 S Landmark Ave, Bloomington, IN 47403 Phone: 812-335-2434 Fax: 812-335-7604 | |
Dr. Michael W Balbus, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-9852 Fax: 812-353-9278 | |
Elda H Simpson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4935 W Arlington Rd, Bloomington, IN 47404 Phone: 812-353-3800 Fax: 812-353-3770 |